EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex and ovarian hormone cycles alter effects of stimulant drugs on mouse dopaminergic signaling

Brooke A Christensen, Jennifer Tat, Michael Z Leonard, Soren D Emerson, Shemuel Roberts, Eleanor B Holmgren, Ainoa Konomi-Pilkati, Hannah B Reiley, Devan M Gomez, Lin Zheng, Hye Jean Yoon, Sofia H Lago und 4 weitere

Journal of Clinical Investigation · 15.05.2026 · 136 (10)

DOI: 10.1172/jci178630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.03.2026. Verfasst von Brooke A Christensen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology. Hauptthemen laut MEDLINE: Dopamine, Signal Transduction, Central Nervous System Stimulants, Dopaminergic Neurons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National institute on drug abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimulant medications are widely prescribed for attention deficit hyperactivity disorder (ADHD) and have significant abuse liability. Here, we show that, consistent with clinical data, female mice exhibited enhanced behavioral sensitivity to stimulants, and we define sex- and hormone-dependent adaptations in the dopamine system that contributed to these effects. Single-nucleus RNA-seq of ventral tegmental area dopamine neurons revealed that projections to the nucleus accumbens (NAc) core, compared with other projection populations, were a hub of sexually dimorphic gene expression, including transcripts regulating dopamine synthesis, and transport. These molecular differences coincided with enhanced dopamine release and clearance in female mice, particularly during phases of the estrous cycle when estradiol levels were high. The stimulants amphetamine (a releaser) and methylphenidate (a reuptake inhibitor) more effectively increased dopamine levels in female mice under certain conditions. However, amphetamine showed more robust hormone-sensitive regulation, with potency reduced by ovariectomy and restored by direct estradiol replacement in the NAc core. Together, the findings indicate that even within a drug class, drugs with different mechanisms of action can leverage different aspects of sexually dimorphic dopamine function. This distinction highlights the notion that sex differences are not uniform but can be differentially sensitive to drug pharmacology. Biological sex and ovarian hormones shape responses to stimulant medications by altering dopamine signaling. Drug effects vary by sex, hormonal state, and mechanism of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopamineSignal TransductionCentral Nervous System StimulantsDopaminergic NeuronsEstrous CycleAmphetamineMethylphenidateSex CharacteristicsAnimalsFemaleMiceNucleus AccumbensMaleVentral Tegmental AreaEstradiol

Stichwörter der Autor:innen

AddictionBehaviorCell biologyNeuroscience

Substanzen

DopamineCentral Nervous System StimulantsAmphetamineMethylphenidateEstradiol

Autor:innen und Institutionen

  • Department of Pharmacology.
  • Vanderbilt Center for Addiction Research.
  • Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark.
  • Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Molecular Physiology and Biophysics and.

Förderung

  • NICHD NIH HHS
  • National institute on drug abuse

Zitieren

APA

Christensen, B. A., Tat, J., Leonard, M. Z., Emerson, S. D., Roberts, S., Holmgren, E. B., Konomi-Pilkati, A., Reiley, H. B., Gomez, D. M., Zheng, L., Yoon, H. J., Lago, S. H., Carr, A. L., Brady, L. J., Chevée, M., & Calipari, E. S. (2026). Sex and ovarian hormone cycles alter effects of stimulant drugs on mouse dopaminergic signaling. Journal of Clinical Investigation, 136(10). https://doi.org/10.1172/jci178630

Vancouver

Christensen BA, Tat J, Leonard MZ, Emerson SD, Roberts S, Holmgren EB, et al. Sex and ovarian hormone cycles alter effects of stimulant drugs on mouse dopaminergic signaling. Journal of Clinical Investigation. 2026;136(10). doi:10.1172/jci178630

BibTeX
@article{Christensen2026,
  author = {Christensen, Brooke A and Tat, Jennifer and Leonard, Michael Z and Emerson, Soren D and Roberts, Shemuel and Holmgren, Eleanor B and Konomi-Pilkati, Ainoa and Reiley, Hannah B and Gomez, Devan M and Zheng, Lin and Yoon, Hye Jean and Lago, Sofia H and Carr, Abigail L and Brady, Lillian J and Chevée, Maxime and Calipari, Erin S},
  title = {Sex and ovarian hormone cycles alter effects of stimulant drugs on mouse dopaminergic signaling},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {10},
  doi = {10.1172/jci178630}
}
Kostenlos starten →